Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
Holding EKSO?
Track your performance easily
EKSO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $3.13
Previous Close$0.58
Volume131.75K
Average Volume (3M)95.14K
Market Cap
$14.21M
Enterprise Value$12.26M
Total Cash (Recent Filing)$8.29M
Total Debt (Recent Filing)$6.35M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Feb 27, 2025EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding21,998,369
10 Day Avg. Volume284,056
30 Day Avg. Volume95,141
Standard Deviation0.27
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)0.80
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit1.35
Enterprise Value/Ebitda-1.34
Forecast
1Y Price Target
$5.50Price Target Upside848.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EKSO BIONICS News
Bulls Say, Bears Say
Bulls Say
Cost ManagementEkso is effectively controlling expenses, leading to better financial health.
Financial PerformanceDespite revenue challenges, Ekso achieved an impressive gross margin of 53.5%.
International GrowthIncreased demand in Europe is expected to drive strong sales for Ekso.
Bears Say
Cash RunwayThe company's present forecasts suggest less than 12 months of cash runway, indicating a likely need to tap the equity markets.
Financial PerformanceEkso Bionics reported revenues of $4.1M, lower than the consensus estimate of $5.5M, and a net loss of $0.10 per share.
Medicare ReimbursementThe entire process of Medicare Part B reimbursement for Indego Personal devices is moving more slowly than anticipated, leading to investor disappointment.
---
Ownership Overview
6.31% Insiders
3.27% Mutual Funds
17.56% Other Institutional Investors
70.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
EKSO FAQ
What was EKSO BIONICS’s price range in the past 12 months?
EKSO BIONICS lowest stock price was $0.50 and its highest was $3.13 in the past 12 months.
What is EKSO BIONICS’s market cap?
Currently, no data Available
When is EKSO BIONICS’s upcoming earnings report date?
EKSO BIONICS’s upcoming earnings report date is Feb 27, 2025 which is in 67 days.
How were EKSO BIONICS’s earnings last quarter?
EKSO BIONICS released its earnings results on Oct 28, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.105 by $0.005.
Is EKSO BIONICS overvalued?
According to Wall Street analysts EKSO BIONICS’s price is currently Undervalued.
Does EKSO BIONICS pay dividends?
EKSO BIONICS does not currently pay dividends.
What is EKSO BIONICS’s EPS estimate?
EKSO BIONICS’s EPS estimate is -$0.08.
How many shares outstanding does EKSO BIONICS have?
EKSO BIONICS has 21,998,370 shares outstanding.
What happened to EKSO BIONICS’s price movement after its last earnings report?
EKSO BIONICS reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.105. Following the earnings report the stock price went down -15.044%.
Which hedge fund is a major shareholder of EKSO BIONICS?
Currently, no hedge funds are holding shares in EKSO
---
EKSO BIONICS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (848.11% Upside)
$5.50 (848.11% Upside)
Blogger Sentiment
Bullish
EKSO Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▲ 4.0%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.47%
12-Months-Change
Fundamentals
Return on Equity
-73.89%
Trailing 12-Months
Asset Growth
-6.33%
Trailing 12-Months
Company Description
EKSO BIONICS
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
EKSO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in CMS claim approval and international sales growth, with improved gross margins and reduced operating expenses, leading to a reduced net loss. However, revenue declined year-over-year with challenges in U.S. sales and the industrial segment.Read More>---
EKSO Stock 12 Month Forecast
Average Price Target
$5.50
▲(848.11% Upside)
Technical Analysis
Best Analysts Covering EKSO
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-33.62%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -33.62% per trade.
---